What are the guidelines for manually operating an Electroconvulsive Therapy (ECT) machine for an adult patient with a history of psychiatric illness undergoing ultra-brief pulse ECT?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Manual Operation of ECT Machine: Step-by-Step Protocol

The manual operation of an ECT machine requires a specialized treatment team, proper patient preparation with anesthesia, and systematic electrode placement with electrical stimulus delivery, following established safety protocols for seizure induction and monitoring. 1

Pre-Treatment Requirements

Treatment Team Assembly

  • Assemble a treatment team consisting of a psychiatrist, personnel experienced in anesthesia, and nursing staff trained in ECT use before any treatment session 1
  • Ensure the anesthesiologist or anesthesia personnel has specific experience treating the patient population (adolescents if applicable, adults otherwise) 1

Patient Preparation

  • Ensure the patient has fasted overnight before moving to the designated ECT treatment area 1
  • Verify completion of comprehensive physical evaluation, appropriate laboratory investigations (CBC, differential WBC, thyroid function, liver function, urinalysis, toxicology screen, ECG, EEG, and brain imaging if indicated), and baseline memory assessment 1, 2
  • Confirm written informed consent has been obtained and an independent second opinion from a psychiatrist knowledgeable about ECT has been documented 1, 2

Anesthesia Administration Protocol

Medication Sequence

  • Administer methohexital as the primary anesthetic agent 1, 2
  • Provide muscle relaxation with succinylcholine 1, 2
  • Consider administering intravenous atropine or glycopyrrolate immediately before ECT to protect against vagally induced bradycardia and arrhythmias, though consensus on routine use is lacking 1
  • Ventilate the patient with 100% oxygen before administering electrical stimulation 1

Electrode Placement Decision

For Ultra-Brief Pulse ECT

  • Begin with unilateral electrode application to the nondominant hemisphere as the preferred initial method 1
  • Switch to bilateral electrode placement if the patient is critically ill with refusal to eat/drink, severe suicidality, uncontrollable mania, or florid psychosis 1, 3
  • For catatonia specifically, use bilateral electrode placement from the outset rather than unilateral 2

Bilateral ECT Indications

  • Implement bilateral ECT immediately if unilateral placement shows inadequate response after 3-4 treatments 4
  • Prioritize bilateral placement over unilateral in very ill patients with active psychotic symptoms, as efficacy outweighs temporary cognitive side effects 3

Electrical Stimulus Delivery

Dosing Strategy

  • Use brief pulse stimulation with individual stimulus titration based on EEG monitoring 5
  • Adjust stimulus dose based on seizure threshold, which should be determined during the first treatment session 5
  • For ultra-brief pulse ECT, use adequate electrical dosing while monitoring for therapeutic seizure induction 2

Treatment Frequency

  • Begin treatment at either two or three times weekly 1, 2
  • Modify the schedule if the patient experiences significant confusion 1
  • Consider increasing to three times weekly if response is inadequate on twice-weekly schedule 3

Intra-Treatment Monitoring

Critical Parameters to Monitor

  • Monitor seizure duration continuously during electrical stimulation 2
  • Maintain continuous monitoring of airway patency throughout the procedure 2
  • Track vital signs including heart rate, blood pressure, and oxygen saturation 2
  • Observe for adverse effects including cardiovascular events, pulmonary complications, and cerebrovascular events 6

Seizure Management

  • Terminate prolonged seizures with additional medications if they occur 3
  • Obtain neurology consultation if recurrent prolonged seizures develop 2

Post-Treatment Protocol

Immediate Recovery

  • Provide observation in a designated recovery area immediately following treatment 2
  • Monitor for at least 24 hours for potential tardive seizures 2
  • Manage common acute adverse effects symptomatically: headache, nausea, vomiting, muscle aches, confusion, and agitation 2, 6

Treatment Course Management

  • Continue ECT series for 6-12 individual sessions total 5
  • Reassess response after every 5-6 treatments by evaluating target symptoms and overall functioning 3
  • Do not prematurely discontinue ECT, as some patients display improvement late in treatment 3
  • Continue beyond the usual 10-12 treatment course if response is inadequate 3

Concurrent Medication Management

Medications to Continue

  • Maintain supportive psychiatric treatment during the ECT course 1, 2
  • Continue olanzapine and similar neuroleptics as part of maintenance strategy if treating psychosis 3

Medications to Discontinue

  • Immediately stop benzodiazepines, as they increase seizure threshold and may prevent adequate therapeutic seizures 3
  • Discontinue carbamazepine due to association with failure to induce seizures 3
  • Stop lithium when clinically possible due to risk of acute brain syndrome 3

Common Pitfalls to Avoid

  • Never continue unilateral ECT indefinitely without switching to bilateral placement in actively psychotic patients 3
  • Do not assume ECT has failed after only 5-6 treatments, as late responders exist and premature discontinuation is a critical error 3
  • Avoid polypharmacy with seizure threshold-elevating medications that sabotage ECT efficacy 3
  • Never delay treatment while attempting prolonged medication adjustments in life-threatening situations such as severe malnutrition, extreme suicidality, or malignant catatonia 4

Safety Profile

  • Serious potentially life-threatening adverse events requiring medical action occur in approximately 0.097% of treatments when performed in a controlled setting 7
  • Most cognitive adverse effects are short-lasting, with troublesome retrograde amnesia rarely persisting beyond 4-8 weeks 5, 6
  • No absolute contraindications exist for ECT, though relative contraindications include CNS tumors with elevated cerebrospinal fluid, active chest infection, and recent myocardial infarction 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Electroconvulsive Therapy for Catatonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Persistent Psychosis During ECT

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Immediate Treatment for Catatonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Adverse Effects of Electroconvulsive Therapy.

The Psychiatric clinics of North America, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.